cbdMD, Inc. to Host Conference Call to Discuss June 30, 2026, Third Quarter Results
cbdMD (NYSE American: YCBD) will host a conference call on Thursday, August 13, 2026 at 4:20 p.m. Eastern Time to discuss its June 30, 2026 third quarter financial results and business progress.
Rhea-AI Summary
cbdMD (NYSE American: YCBD) will host a conference call on Thursday, August 13, 2026 at 4:20 p.m. Eastern Time to discuss its June 30, 2026 third quarter financial results and business progress. Investors can join via phone at 888-880-3330 or through a webcast with replay access available until August 13, 2027 at https://app.webinar.net/w4b2GxXG7Kv.
Positive
- None.
Negative
- None.
Details
News Market Reaction – YCBD
In the Aug 10 session, YCBD gained 0.18%, reflecting a mild positive market reaction. Argus tracked a peak move of +10.2% during that session. Our momentum scanner triggered 2 alerts that day, indicating moderate trading interest and price volatility.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
- Reporting Period
- June 30, 2026
- Third quarter financial results
- Conference Call Date
- August 13, 2026
- Scheduled results discussion
- Conference Call Time
- 4:20 p.m. Eastern Time
- August 13, 2026
- Webcast Replay Availability
- Through August 13, 2027
- Webcast replay
Previous Conferences,earnings date Reports
-
Scheduled discussion of March 31, 2026 second-quarter results and business progress
-
Scheduled discussion of December 31, 2025 first-quarter results and business progress
-
Scheduled discussion of fourth-quarter and fiscal-year 2025 results
-
Scheduled discussion of June 30, 2025 third-quarter results
-
Scheduled discussion of March 31, 2025 second-quarter results
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
CONFERENCE CALL DETAILS
Thursday, August 13, 2026, 4:20 p.m. Eastern Time
Webcast/Webcast Replay link - available through August 13, 2027:
https://app.webinar.net/w4b2GxXG7Kv
About cbdMD, Inc.
cbdMD, Inc. (NYSE American: YCBD) is one of the leading and most highly trusted and most recognized cannabidiol (CBD) brands with a comprehensive line of U.S. produced THC-free1 CBD products and an array of Farm Act compliant Delta 9 products. Our Paw CBD brand of pet products includes veterinarian-formulated products and our ATRx brand features functional mushroom products. In addition, we operate Herbal Oasis, a premium, award winning THC-infused social seltzer that blends cannabinoids and nootropic mushrooms to deliver a fast-acting, functional beverage made for presence and connection. With an alcohol-free formula and wellness-forward ingredients, Oasis invites a better way to drink-one rooted in clarity, balance, and joy. To learn more about cbdMD and our comprehensive line of U.S. grown, THC-free1 CBD and Full Spectrum products as well as our other brands, please visit www.cbdmd.com, www.pawcbd.com, ATRxlabs.com, www.bluebirdbotanicals.com, or Herbaloasis.com, follow cbdMD on Instagram and Facebook, or visit one of the thousands of retail outlets that carry cbdMD's products.
(1) THC-free is defined as below the level of detection using validated scientific analytical methods.
Contact Information:
cbdMD, Inc.
Ronan Kennedy, CEO and CFO
Phone: +1 (704) 445-3064
email: IR@cbdmd.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/cbdmd-inc-to-host-conference-call-to-discuss-june-30-2026-third-quarter-results-302847406.html
SOURCE cbdMD, Inc.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.